Atlantic Union Bankshares Corp Alnylam Pharmaceuticals, Inc. Call Options Transaction History
Atlantic Union Bankshares Corp
- $4.2 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALNY
# of Institutions
746Shares Held
110MCall Options Held
966KPut Options Held
841K-
Capital World Investors Los Angeles, CA16.7MShares$7.35 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$5.73 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.19 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$3.14 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.94 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $54B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...